Shifts in blast cell phenotype and karyotype at relapse of childhood lymphoblastic leukemia.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Blood

• Publication date

  1986-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V68.6.1306.1306PMID 2946333
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intensive retreatment of childhood acute lymphoblastic leukemia in first bone marrow relapse. A Pediatric Oncology Group Study.

  1986cited by this paper
• Clinical and laboratory characteristics of acute leukemia with the 4;11 translocation

  1986cited by this paper
• Clinical and hematologic characteristics in acute leukemia with 11q23 translocations.

  1986cited by this paper
• Amplification and rearrangement of Hu-ets-1 in leukemia and lymphoma with involvement of 11q23.

  1986cited by this paper
• Clinical and laboratory characteristics of acute leukemia with the 4;11 translocation.

  1986cited by this paper
• Clinical relevance of lymphoblast biological features in children with acute lymphoblastic leukemia.

  1985cited by this paper
• Acute leukemias associated with the 4;11 chromosome translocation have rearranged immunoglobulin heavy chain genes.

  1985cited by this paper
• Transfer and expression of the gene encoding a human myeloid membrane antigen (gp150).

  1985cited by this paper
• Elective testicular biopsy during chemotherapy for childhood leukaemia is of no clinical value.

  1985cited by this paper
• A direct bone marrow chromosome technique for acute lymphoblastic leukemia.

  1984cited by this paper
• Monoclonal antibody MCS-2 as the marker of phorbol diester-induced myeloid differentiation in acute undifferentiated leukemia.

  1984cited by this paper
• Chromosomal localization of the human proto-oncogene c-ets

  1984cited by this paper
• Significance of abnormalities involving chromosomal segment 11q22-25 in acute leukemia.

  1984cited by this paper
• Outcome following late marrow relapse in childhood acute lymphoblastic leukemia.

  1984cited by this paper
• Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.

  1984cited by this paper
• Lineage switch in acute leukemia.

  1984cited by this paper
• Phenotypic conversion of acute leukaemia from T‐lymphoblastic to myeloblastic induced by therapy with 2′‐deoxycoformycin

  1983cited by this paper
• Utilization of monoclonal antibodies in the treatment of leukemia and lymphoma.

  1982cited by this paper
• Surface markers on leukemia and lymphoma cells: recent advances.

  1982cited by this paper
• Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse.

  1982cited by this paper
• Normal and malignant human myelocytic and monocytic cells identified by monoclonal antibodies.

  1982cited by this paper
• Monoclonal antibodies OKT 11 and OKT 11A have pan‐T reactivity and block sheep erythrocyte “receptors”

  1982cited by this paper
• My-1, new myeloid-specific antigen identified by a mouse monoclonal antibody.

  1981cited by this paper
• Expression of normal monocyte-macrophage differentiation antigens on HL60 promyelocytes undergoing differentiation induced by leukocyte-conditioned medium or phorbol diester.

  1981cited by this paper
• Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.

  1981cited by this paper
• Biochemical studies of the human thymocyte cell-surface antigens T6, T9 and T10.

  1981cited by this paper
• Human T cell antigens defined by monoclonal antibodies: the 65,000-dalton antigen of T cells (T65) is also found on chronic lymphocytic leukemia cells bearing surface immunoglobulin.

  1980cited by this paper
• A monoclonal antibody to human acute lymphoblastic leukaemia antigen

  1980cited by this paper
• Acute lymphoblastic leukaemia associated antigen. III ALterations in expression during treatment and in relapse.

  1980cited by this paper
• Separation of functional subsets of human T cells by a monoclonal antibody.

  1979cited by this paper
• Shifts in expression of cell membrane phenotypes in childhood lymphoid malignancies at relapse.

  1979cited by this paper
• Terminal deoxynucleotidyl transferase immunofluorescence of bone marrow smears: experience in 156 cases.

  1979cited by this paper
• Pre-B-cell leukemia. A new phenotype of childhood lymphoblastic leukemia.

  1978cited by this paper
• Proposals for the Classification of the Acute Leukaemias French‐American‐British (FAB) Co‐operative Group

  1976cited by this paper
• A rapid banding technique for human chromosomes.

  1971cited by this paper

• T and NK lymphoblastic leukemia/lymphoma: Report from the 2023 SH/EAHP Workshop.

  2025cites this paper
• LINEAGE SWITCH - CASE REPORT SHOWING THERAPY RELATED CLONAL SELECTION AS THE ETIOLOGY

  2025cites this paper
• Lineage Switch in an Infant B-Lymphoblastic Leukemia With t(1;11)(p32;q23); KMT2A/EPS15, Following Blinatumomab Therapy

  2021cites this paper
• Myeloid leukemia switch as immune escape from CD19 chimeric antigen receptor (CAR) therapy.

  2016cites this paper
• CD7 aberrant expression led to a lineage switch at relapsed childhood acute pre-B lymphoblastic leukemia

  2016cites this paper
• The Biology of Relapsed Acute Lymphoblastic Leukemia: Opportunities for Therapeutic Interventions

  2014cites this paper
• An unusual case of phenotype switch between AML FAB subtypes

  2014cites this paper
• Lineage Switching in Acute Leukemias: A Consequence of Stem Cell Plasticity?

  2012cites this paper
• acute lymphoblastic leukemia Cytogenetically different leukemic clones at relapse of childhood

  2011cites this paper
• Early Lineage Switch from T-Acute Lymphoblastic Leukaemia to Common B-All

  2011cites this paper
• with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic Prognostic importance of structural chromosomal abnormalities in children

  2011cites this paper
• Lineage Switch at Relapse of Childhood Acute Leukemia: A Report of Four Cases

  2011cites this paper
• ABL deletion without associated BCR-ABL in precursor B-cell acute lymphoblastic leukemia.

  2009cites this paper
• Relationship between HLA‐DP supertype and survival in childhood acute lymphoblastic leukaemia: evidence for selective loss of immunological control of residual disease?

  2009cites this paper
• Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy.

  2007cites this paper
• Therapy-related AML

  2007cites this paper
• Phase I Clinical Trial of Orally Administered (Idarubicin) with Pharmacokinetic and in Vitro Drug Sensitivity Testing in Children with Refractory Leukemia1

  2006cites this paper
• Phase I Clinical Trial of Orally Administered 4-Demethoxydaunorubicin ( Idarubicin ) with Pharmacokinetic and in Vitro Drug Sensitivity Testing in Children with Refractory Leukemia 1

  2006cites this paper
• Prognostic Importance of Structural Chromosomal Abnormalities in Children With Hyperdiploid Chromosomes) Acute Lymphoblastic Leukemia

  2005cites this paper
• Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: Implications for residual disease detection: A report from the children's oncology group

  2005cites this paper
• Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia

  2004cites this paper
• Treatment of Relapsed Acute Lymphoblastic Leukemia

  2003cites this paper
• Minimal residual disease monitoring by flow cytometry.

  2003cites this paper
• Involvement in De Novo and Secondary Leukemias With Diverse Chromosome l l q 2 3 Abnormalities

  2003cites this paper
• Salvage therapy for refractory or relapsed acute lymphocytic leukemia.

  2001cites this paper
• Immunophenotypic and cytogenetic changes in acute leukaemia at relapse.

  2001cites this paper
• Cytogenetic abnormalities during clinical, immunophenotypic, and molecular remission in pediatric acute lymphoblastic leukemia.

  2000cites this paper
• Leukemia Relapse Reconsidered from the Molecular Aspect

  2000cites this paper
• Detection of abnormalities in B‐cell differentiation pattern is a useful tool to predict relapse in precursor‐B‐ALL

  1999cites this paper
• Cytogenetic polyclonality in hematologic malignancies

  1999cites this paper
• The clinical significance of detection of residual disease in childhood ALL.

  1998cites this paper
• Investigation of the clonality and minimal residual disease in haematological malignancy using fluorescence in situ hybridization.

  1998cites this paper
• Residual disease in acute lymphoblastic leukemia of childhood: methods of detection and clinical relevance.

  1998cites this paper
• Immunophenotypic Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia

  1997cites this paper
• Acute Leukemias VI

  1997influential citation
• Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications

  1997cites this paper
• Clonality switch in acute myeloid leukemia.

  1996cites this paper
• Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease.

  1996cites this paper
• A t(9;11) translocation in childhood acute mixed leukemia.

  1996cites this paper
• Therapy-related myeloid leukemia.

  1996cites this paper
• Monoclonal antibodies in the management of acute leukemia

  1995cites this paper
• New translocation t(2;13)(p12;q34) and rearrangement of the MLL gene in a childhood leukemia cell line

  1995cites this paper
• Myeloid lineage involvement in acute lymphoblastic leukemia: a morphology antibody chromosomes (MAC) study.

  1995cites this paper
• Molecular immaturity of the immune receptor genes in a case of acute leukaemia with complete lymphoid lineage switch

  1995cites this paper
• Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.

  1995cites this paper
• Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes

  1995cites this paper
• Epipodophyllotoxin-related acute myeloid leukemia: a study of 35 cases.

  1995cites this paper
• The study of minimal residual disease in acute lymphoblastic leukaemia

  1995cites this paper
• Immunogenetic studies in childhood acute lymphoblastic leukemia : analysis at diagnosis and relapse

  1994cites this paper
• Lineage switch in Philadelphia chromosome‐ positive acute lymphoblastic leukemia

  1994cites this paper
• Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis.

  1994cites this paper
• In vivo clonal evolution of pre-B to B-cell acute lymphoblastic leukemia in childhood.

  1994cites this paper
• Quantitative immune phenotyping: a new dimension for the monitoring of haemopoietic malignancies.

  1994cites this paper
• Genetic changes: relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia.

  1994cites this paper
• Differences in Immunoglobulin and T-Cell Receptor Gene Rearrangement Patterns in Acute Lymphoblastic Leukemia Between Diagnosis and Relapse

  1994cites this paper
• 1 Genetic changes: Relevance for diagnosis and detection of minimal residual disease in acute lymphoblastic leukaemia

  1994cites this paper
• Cytogenetic heterogeneity in t(11;19) acute leukemia: clinical, hematological and cytogenetic analyses of 48 patients--updated published cases and 16 new observations.

  1993cites this paper
• Detection of minimal residual disease in ALL.

  1993cites this paper
• Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.

  1993cites this paper
• Cytogenetically different leukemic clones at relapse of childhood acute lymphoblastic leukemia.

  1993cites this paper
• Immunophenotypic and immunogenotypic detection of minimal residual disease in acute lymphoblastic leukemia.

  1993cites this paper
• Translocation t(11;19) (q23;p13) in a child with myelomonocytic leukemia following 2 years after chemotherapy for pneumoblastoma.

  1993cites this paper
• HRX involvement in de novo and secondary leukemias with diverse chromosome 11q23 abnormalities.

  1993cites this paper
• Flow cytometric determination of atypical antigen expression in acute leukemia for the study of minimal residual disease.

  1992cites this paper
• Cytogenetic abnormalities in childhood acute lymphoblastic leukemia correlates with clinical features and treatment outcome.

  1992cites this paper
• Childhood acute lymphoblastic leukemia with both t(1;19) and t(9;22).

  1992cites this paper
• Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study.

  1992cites this paper
• Leukemia: stem cells, preleukemia and cure.

  1992cites this paper
• The detection of minimal residual disease in acute lymphoblastic leukaemia.

  1992cites this paper
• A new nonrandom chromosomal abnormality, t(2;16)(p11.2;p11.2), possibly associated with poor outcome in childhood acute lymphoblastic leukemia.

  1992cites this paper
• X;6 translocation in a child with congenital acute lymphocytic leukemia

  1992cites this paper
• Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction.

  1992cites this paper
• Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders.

  1991cites this paper
• Relationship between clonality and transformation in acute leukemia.

  1991cites this paper
• Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse.

  1991cites this paper
• Acute Myeloid Leukaemia Following Matched Allogeneic Bone Marrow Transplantation for T-Cell Lymphoblastic Lymphoma.

  1991cites this paper
• Multiparameter analysis of acute mixed lineage leukemia: correlation of a B/myeloid immunophenotype and immunoglobulin and T-cell receptor gene rearrangements with the presence of the Philadelphia chromosome translocation in acute leukemias with myeloid morphology.

  1991cites this paper
• Early embryonal/fetal lymphopoietic ontogeny and leukemogenesis

  1991cites this paper
• Pre-B Acute Lymphoblastic Leukemia During a Complete Remission in T-Acute Lymphoblastic Leukemia.

  1991cites this paper
• Detecting minimal residual leukemia.

  1991cites this paper
• Childhood acute leukemia with t(11;19) (q23;p13).

  1991cites this paper
• Alterations in immunoglobulin or T cell receptor gene rearrangement at relapse: involvement of 11q23 and changes in immunophenotype.

  1990cites this paper
• New Concepts in Management of Acute Leukemia

  1990cites this paper
• Karyotypic changes from initial diagnosis to relapse in childhood acute leukemia.

  1990cites this paper
• 11q23 abnormalities in children with acute nonlymphocytic leukemia (M4-M5). Association with previous chemotherapy.

  1990cites this paper
• Use of Lymphoid Progenitor Cell Assays for a More Detailed Analysis of the Cytogenetic Changes Occurring During Clonal Evolution in Acute Lymphoblastic Leukemia.

  1990cites this paper
• Undifferentiated acute leukemia and lineage infidelity (difficulties in classification and management).

  1990cites this paper
• Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia.

  1990cites this paper
• Diagnosis and management of relapse in acute lymphoblastic leukemia.

  1990cites this paper
• Biology and Clinical Significance of Cytogenetic Abnormalities in Childhood Acute Lymphoblastic Leukemia

  1990cites this paper
• Immunologic classification of acute lymphoblastic leukemia.

  1990cites this paper
• Karyotypically unrelated clones in acute leukemias and myelodysplastic syndromes.

  1990cites this paper
• Regulation of human B-cell ontogeny.

  1990cites this paper
• Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemia.

  1990cites this paper
• Immunologic markers in childhood acute lymphoblastic leukemia.

  1990cites this paper
• Acute Leukemia with a Translocation T(4;11)(q21;q23): a Distinct Clinicopathological Entity: Report of a Case with Cytogenetic Clonal Evolution and Review of 146 Cases of the Literature.

  1990cites this paper
• Detection of minimal residual disease in leukemias: a critical approach.

  1990cites this paper
• Common ALLで発症し, 再発時の芽球にperoxidase活性とmyeloid抗原の発現がみられたbiphenotypic leukemia の一症例

  1989cites this paper
• Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia.

  1989cites this paper
• Prognostic importance of structural chromosomal abnormalities in children with hyperdiploid (greater than 50 chromosomes) acute lymphoblastic leukemia.

  1989cites this paper